Under normal conditions, production andclearance of ET-1 are balanced, but in diseases such as pulmonary arterialhypertension (PAH), circulating levels of ET-1 rise, with detrimental effects[25]. This evidence concerns the gene EDN1 and pulmonary arterial hypertension.